Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 28 Feb 2025

Undergraduate pharmacy students’ preference for case-based learning: a discrete choice experiment in China

in Drugs Outcomes Research and Policies

Zhibo Guo
Yuxing He
Jianzhou Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529492

488 views

Review

Published on 26 Feb 2025

Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma

in Drugs Outcomes Research and Policies

Zhou Liu
Liang Zhang
Wei Peng
Qianqian Chen
Yanguang Hou
Liying Zhan
Guang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1543612

960 views

Original Research

Published on 25 Feb 2025

Community pharmacy professionals’ knowledge, attitudes, and practices toward substandard and falsified medicines and associated factors in Bahir Dar City, Northwest Ethiopia

in Drugs Outcomes Research and Policies

Biset Asrade Mekonnen
Kidest Berhanu
Nebiyu Solomon
Minichil Chanie Worku
Yeniewa Kerie Anagaw

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1523709

794 views

Original Research

Published on 25 Feb 2025

Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world population

in Drugs Outcomes Research and Policies

Xinyu Zou
Xingchen He
Qingyang Shi
Si Wang
Nan Li
Yiling Zhou
Ming Hu
Li Luo
Yiwen Shen
Ye Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527972

706 views

Perspective

Published on 24 Feb 2025

What role for real-world evidence in market access of biosimilars?

in Drugs Outcomes Research and Policies

Steven Simoens
Catherine M. Lockhart
Delphine F. Courmier

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538866

845 views

Original Research

Published on 21 Feb 2025

Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis

in Drugs Outcomes Research and Policies

Zhi-Hang Lin
Can-Ming Wang
Li-Li Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1458792

361 views

Original Research

Published on 19 Feb 2025

Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study

in Drugs Outcomes Research and Policies

Bin Zhu
Zijun He
Mingfen Wu
Jiping Huo
Zhigang Zhao
Wei Guo
Li Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533709

969 views

Original Research

Published on 17 Feb 2025

Impact of the national health insurance coverage policy on mecapegfilgrastim utilization for chemoradiotherapy-induced neutropenia in cancer patients in China: a retrospective real-world analysis

in Drugs Outcomes Research and Policies

Wenqing Fang
Jizhong He
Ying Wang
Yulei Zhu
Xiaodan Qian
Dan Su
Jinhong Gong
Jingjing Shang
Yuan He
Hong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546261

588 views

Original Research

Published on 13 Feb 2025

Time in the therapeutic range, bleeding event, and their determinants in older patients with atrial fibrillation on warfarin in Ethiopia: multicenter cross-sectional study

in Drugs Outcomes Research and Policies

Zenaw Debasu Addisu
Desalegn Getnet Demsie
Chernet Tafere
Taklo Simeneh Yazie
Destaw Endeshaw
Bereket Bahiru Tefera
Malede Berihun
Dessale Abate Beyene

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541592

750 views

Brief Research Report

Published on 13 Feb 2025

Consumers’ expected information search behavior for a pharmaceutical treatment

in Drugs Outcomes Research and Policies

Yifei Liu
Jack E. Fincham
Morgan L. Sperry

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1466352

373 views

Original Research

Published on 11 Feb 2025

Exploring information technology utilization and needs in community pharmacies: a cross-sectional survey in Shanghai, China

in Drugs Outcomes Research and Policies

Qin Li
Zhao Jin
Yun Liao
Huihua Dai
Jie Meng
Ling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554141

504 views

Original Research

Published on 11 Feb 2025

Profile of STING agonist and inhibitor research: a bibliometric analysis

in Drugs Outcomes Research and Policies

Xuemei Wang
Qian Wang
Yidan Gao
Lijuan Jiang
Lingli Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528459

1,293 views

Perspective

Published on 10 Feb 2025

Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges

in Drugs Outcomes Research and Policies

Sulaiman Muhammad Musa
Usman Abubakar Haruna
Lukman Jibril Aliyu
Mubarak Zubairu
Don Eliseo Lucero-Prisno

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531141

1,300 views

Systematic Review

Published on 07 Feb 2025

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness

in Drugs Outcomes Research and Policies

Narcis Cardoner
Luis Gutiérrez-Rojas
Pilar Saiz
Guillermo Lahera
Miguel Ángel Álvarez-Mon
Pino Alonso Ortega
María Pérez-Páramo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1483770

2,144 views

Original Research

Published on 05 Feb 2025

Drug utilization study of antiparkinsonian medication in Romania during 25 years

in Drugs Outcomes Research and Policies

Camelia Bucsa
Denisa Bruhs
Anamaria Apan
Elena Francu
Cristina Mogosan
Irina Iaru

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534344

786 views

Editorial

Published on 31 Jan 2025

Editorial: The role of validated tools, including pictorial aids, to support medication adherence and counselling

in Drugs Outcomes Research and Policies

Piotr Merks
Agnieszka Neumann-Podczaska
Regis Vaillancourt

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561101

484 views